ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting
Client Age
Topic Area
Experience [clear]
Course Format
SIG
Instructional Level
Results 401 - 410 of 540
Presenter(s): Michelle Leigh Arnold, AuD, CCC-A; Debra Dobbs, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Older adults must make important decisions about their end-of-life care, and those with hearing and other communication disorders need special accommodations to participate in these important decisions to the fullest extent possible. This session discusses the communication needs of patients in the final stages of life, including the use of various hearing technologies, such as hearing aids, personal sound amplifiers, and pocket talkers. The presenters discuss tools to facilitate conversations among patients, family members, and caregivers.
Presenter(s): Sarah Warren, MA; Caroline Bergner, Esq.; Meghan Ryan, MSL, Health Policy and Law
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Audiologists and SLPs who work in inpatient and home health care settings and supervise graduate students, clinical fellows (CFs), and assistants need to comply with payer requirements to avoid denials or unfavorable audits that could lead to recoupment and civil or criminal penalties. This on demand webinar outlines the state and federal legal supervision requirements as well as payment considerations when supervising students and support personnel.
Presenter(s): Megan A Morris, PhD, MPH, CCC-SLP; Christina Studts, PhD, MSPH, LCSW
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This course describes a mixed methods program of research aimed at adapting and testing the effectiveness and implementation of behavioral parent training (BPT) with young children who are deaf/hard of hearing (DHH) and use hearing aids or cochlear implants.
Webinar cover image
Presenter(s): Kathleen J Riley, AuD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Cytomegalovirus (CMV) is a common and pervasive virus, and undiagnosed cases can have a range of impacts on children. This on demand webinar will discuss the myths and facts about congenital cytomegalovirus (cCMV) and the key role educational audiologists play in recognizing the connections between student challenges and cCMV. The presenter will also discuss the modes of transmission of CMV and necessary precautions.
Presenter(s): Devin L. McCaslin, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session will examine the diagnosis and treatment of persistent postural-perceptual dizziness (PPPD). The session will explore the recently defined criteria for the presentation and symptoms of the disorder as well as describe current and emerging research that is helping clinicians and researchers better understand it. The speaker will also discuss how chronic co-morbid disorders such as migraine and Meniere’s disease should be factored into the treatment of this disorder.
Presenter(s): Alyssa K Dosen; Megan McKim
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session explores the strong and complex relationship between pediatric mental and behavioral health and skills in cognition, language, and social communication. The session reviews a speech-language pathology program and service delivery model for youth receiving acute psychiatric care at one of the nation’s top pediatric hospitals, emphasizing the distinct role of SLPs in providing care to youth with mental and behavioral illnesses.
Presenter(s): Gayla L. Poling, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hundreds of medications commonly prescribed for anticancer treatments and some infections are known to cause auditory and/or vestibular dysfunction, known as ototoxicity. This course discusses early detection of ototoxicity through increased awareness, leveraging current tools, and clinical practice approaches for serial monitoring, all of which can provide care teams opportunities to identify adverse effects, modify treatment plans to mitigate hearing loss, and utilize individualized interventions. The speaker discusses strategies for preventing or minimizing cochlear damage to preserve quality of life for patients receiving treatment and to reduce the societal burden of hearing loss.
Presenter(s): Cynthia Hogan,PhD, CCC-A; Janalene Jacobson,AuD, CCC-A; Melanie Meldrum,AuD, CCC-A; Sarah Ostlie, AuD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course explores the most commonly fit devices for patients whose hearing is significantly poorer in one ear than the other (e.g., single-sided deafness or asymmetric hearing loss) and identify factors that impact device selection and hearing management. Using data analysis and case examples from their clinic, the speakers discuss management options for asymmetrical sensorineural hearing loss, including traditional hearing aids, Bi-CROS devices, bone conduction devices (BCD), and cochlear implants (all with or without assistive devices).This course – part of the SIGnature Series – was developed by SIG 6: Hearing and Hearing Disorders: Research and Diagnostics.
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
Webinar product cover
Presenter(s): Derek J Stiles, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Congenital cytomegalovirus (cCMV) infection ranks among the leading causes of hearing loss in children. This on demand webinar will explore the characteristics of cCMV and how it affects hearing, cognition, and movement as well as strategies for clinical care, advocacy, and public health as it relates to cCMV.
<< 37 38 39 40 41 42 43 44 45 46 >>